Life Sciences & Pharma Collection

The **Life Sciences & Pharma Collection** data product from Springer Nature offers a meticulously curated set of scholarly journals and ebooks, ensuring broad access to the latest research and insights. This collection helps researchers maintain high data integrity and track post-publication changes.

This extensive portfolio features **over 1,600 journals and ebooks from Nature, Springer, and BMC**, spanning drug discovery, molecular biology, clinical pharmacology, biotechnology, and related fields, providing access to publications **from 2020 to 2024**. It includes peer-reviewed articles/chapters, and post-publication notices (retractions/corrections).

**Key Journals Included:**

- **Nature Protocols (Impact Factor: 79.8):** Covers new techniques and technologies, as well as established methods, used in all fields of the biological, chemical, and clinical sciences. Each protocol contains a full list of reagents and equipment, timing information, and step-by-step procedures, along with information on designing and adapting the technique, its advantages and limitations compared to alternatives, troubleshooting, analyzing data, and interpreting results. 

- **Nature Methods (Impact Factor: 36.1):** A forum for the publication of novel methods and significant improvements to tried-and-tested basic research techniques in the life sciences. 

- **Nature Immunology (Impact Factor: 27.8):** A multidisciplinary journal that publishes papers of the highest quality and significance in all areas of immunology. 

Tap into this rich repository to fuel competitive research in drug discovery, molecular biology, clinical pharmacology, and biotechnology. Whether you’re conducting literature reviews, powering text and data mining, or benchmarking against industry trends, this comprehensive data source is built to drive innovation and accelerate your breakthroughs.

# **Our Workflow: Tailored to Empower Your Research and Innovation**

At Springer Nature, we focus on delivering accessible, scalable, and impactful data solutions designed for a diverse range of users and fields.

The steps include:

- **Needs Analysis:** Completion of the needs analysis to understand your requirements.
- **Consultation:** Engage in a full consultation with our experts to tailor the best solution for you.
- **Customer Proposal:** Receive a tailored proposal, including pricing and licensing terms, to match your goals.
- **Flexible License Terms:** Review of terms to suit your specific needs (e.g., legal changes, vendor approvals).
- **Implementation and Delivery:** Seamless onboarding, setup, and delivery of your chosen solution, with full support and training.

# **Tables & Fields**

**ARTICLES_CHAPTERS_FULLTEXT**

Contains full text for articles, linked by DOI to metadata

DOCUMENT_ID

DOI

FULL_TEXT

**ARTICLES_CHAPTERS_METADATA**

Chapter/Articles Metadata Springer Nature Journal and Book corpus with DOI as primary key

ABSTRACT_LANG

ABSTRACT_TEXT

BOOK

CATEGORY

CLASSIFICATIONS

CONTAINER_ID

CONTAINSESM

COPYRIGHT_YEAR

DOCTYPE

DOCUMENT_ACCEPTED

**ARTICLES_CHAPTERS_KEYWORDS**

Chapter/Articles keywords by source and language; , linked by DOI to metadata

DOI

KEYWORD

KEYWORD_LANGUAGE

KEYWORD_SOURCE

**ARTICLES_CHAPTERS_AUTHORS**

Chapter/Articles Author Information, linked by DOI to metadata

CORRESPONDING

DOCUMENT_ID

DOI

FAMILY_NAME

GIVEN_NAME

LOCATION

NAME

ORCID

SEQUENCE

**ARTICLES_CHAPTERS_ERRATA**

Errata for Chapters and Articles

CATEGORY

DOCTYPE

DOI

PUBLISHED_ON

RELATED_DOI

RELATED_DOITYPE

# **Access and Licensing Terms**

Access to Springer Nature data via Snowflake is governed by a separate agreement and is not automatically granted. Please note the following:

- **No data will be made available via Snowflake** until our licensing terms have been formally accepted.

- **Snowflake is not authorized** to grant access to or license our content on our behalf.

- **All access requests and licensing inquiries** must be directed to us directly.

- All service level commitments, product **offerings, and commercial terms** are defined exclusively by Springer Nature.

- In the event of any discrepancy between Snowflake’s terms and Springer Nature Terms, **Springer Nature Terms shall prevail**.

For access and licensing, please contact us directly.

原始信息汇总

Life Sciences & Pharma Collection 数据集概述

数据集基本信息

• 提供方: Springer Nature
• 数据集名称: Life Sciences & Pharma Collection
• 描述: 精心策划的健康与生命科学领域的学术期刊和电子书集合，确保广泛获取最新研究和见解。帮助研究人员保持高数据完整性并跟踪发表后的变化。
• 时间覆盖范围: 2020年至2024年
• 数据更新频率: 每月
• 地理覆盖范围: 全球，按国家细分

数据集内容

• 包含内容: 超过1,600种来自Nature、Springer和BMC的期刊和电子书
• 领域覆盖: 药物发现、分子生物学、临床药理学、生物技术及相关领域
• 内容类型: 同行评审的文章/章节，以及发表后通知（撤回/更正）

主要期刊

• Nature Protocols (影响因子: 79.8): 涵盖生物、化学和临床科学领域的新技术和现有方法。
• Nature Methods (影响因子: 36.1): 生命科学领域新方法和基本研究技术改进的论坛。
• Nature Immunology (影响因子: 27.8): 发表免疫学领域最高质量和重要性的多学科期刊。

数据表结构

ARTICLES_CHAPTERS_FULLTEXT

• 包含全文文章，通过DOI链接到元数据
• 字段: DOCUMENT_ID, DOI, FULL_TEXT

ARTICLES_CHAPTERS_METADATA

• Springer Nature期刊和书籍语料库的章节/文章元数据，DOI为主键
• 字段: ABSTRACT_LANG, ABSTRACT_TEXT, BOOK, CATEGORY, CLASSIFICATIONS, CONTAINER_ID, CONTAINSESM, COPYRIGHT_YEAR, DOCTYPE, DOCUMENT_ACCEPTED

ARTICLES_CHAPTERS_KEYWORDS

• 章节/文章关键词，按来源和语言分类，通过DOI链接到元数据
• 字段: DOI, KEYWORD, KEYWORD_LANGUAGE, KEYWORD_SOURCE

ARTICLES_CHAPTERS_AUTHORS

• 章节/文章作者信息，通过DOI链接到元数据
• 字段: CORRESPONDING, DOCUMENT_ID, DOI, FAMILY_NAME, GIVEN_NAME, LOCATION, NAME, ORCID, SEQUENCE

ARTICLES_CHAPTERS_ERRATA

• 章节和文章的勘误
• 字段: CATEGORY, DOCTYPE, DOI, PUBLISHED_ON, RELATED_DOI, RELATED_DOITYPE

访问与许可条款

• 通过Snowflake访问Springer Nature数据需单独协议，不自动授予。
• 所有访问请求和许可查询必须直接联系Springer Nature。
• Springer Nature的条款优先于Snowflake的条款。

商业需求

• 竞争与商业智能: 识别模式和趋势，进行市场分析和跨区域分析。
• 产品组合策略与产品规划: 趋势评估、竞争基准测试和基准研究。
• 研发: 加速研发过程，构建知识图谱，进行NLP文本挖掘和文献计量分析。

使用示例

• 全文内容可用性分析: 查询哪些文章同时具有元数据和全文内容。
• 按关键词和类别的研究文章: 结合类别过滤和关键词搜索发现相关内容。
• 带摘要的生命科学研究文章: 检索带有摘要文本的研究文章。
• 文章和章节的更正和撤回通知: 检索有更正可用的文章或章节。

联系方式

• 销售: [e-mail]
• 支持: [e-mail]

云区域可用性

AWS

• 非洲（开普敦）
• 亚太（雅加达）
• 亚太（孟买）
• 亚太（大阪）
• 其他45个地区

搜集汇总

背景与挑战

背景概述

该数据集是Springer Nature提供的生命科学与制药领域数据产品，包含2020年至2024年间的超过1,600种期刊和电子书，涵盖药物发现、分子生物学、临床药理学和生物技术等主题。它提供全文、元数据和作者信息等结构化数据，但访问需通过Springer Nature的单独许可协议进行。